Private equity firms lead bidding for AstraZeneca's Astra Tech unit
This article was originally published in Clinica
Several private equity companies are still in the running to acquire AstraZeneca's Astra Tech dental implant and medical device unit, with the second round of bidding due today. According to The Telegraph, PAI Partners, Cinven and Bridgepoint are all preparing bids for the medical device unit, while Swedish firm EQT is planning to bid for the whole unit.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.